Navigation Links
GranuFlo Recall Website Launched By Hissey Kientz, LLP Law Firm
Date:1/21/2013

Austin, Texas (PRWEB) January 21, 2013

The law firm of Hissey Kientz, LLP is announcing the launch of its new website, GranuFlo Recall Help (http://www.granuflorecallhelp.com/). The site will serve as a source for news and legal information for patients and their families who have experienced side effects after receiving hemodialysis treatment with GranuFlo or NaturaLyte dialysate concentrates.

The Food and Drug Administration (FDA) issued a Class 1 Recall of GranuFlo dry acid concentrate and NaturaLyte liquid acid concentrate in March 2012 after it was presented with a leaked internal memo from GranuFlo and NaturaLyte manufacturer Fresenius Medical Care (FMC).

GranuFlo and NaturaLyte acid concentrates contain bicarbonate, which is used during hemodialysis treatment to neutralize acid build up in the blood. When patients have elevated pre-dialysis bicarbonate blood levels, the addition of GranuFlo or NaturaLyte could raise bicarbonate levels to dangerous heights, resulting in serious side effects such as heart attack, stroke or sudden death.

In their November 2011 internal memo, Fresenius Medical Care warned that patients with elevated bicarbonate levels were six times more likely to suffer a heart attack or sudden cardiac death from GranuFlo or NaturaLyte than patients using other dialysis products. Fresenius also reported that 941 patients had experienced sudden cardiac arrest within their dialysis clinics in 2010 after undergoing hemodialysis treatment with GranuFlo or NaturaLyte.

According to The New York Times, Fresenius Medical Care issued this memo to dialysis centers owned by Fresenius, but did not warn thousands of non-Fresenius owned dialysis clinics using GranuFlo and NaturaLyte products until March 2012.

Patients who have experienced heart attack, stroke, or other injuries after being treated with GranuFlo or NaturaLyte may wish to speak with a lawyer to find out if they are eligible to file a lawsuit. For more information about whether you may have a case, contact the attorneys at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by email at info(at)hkllp(dot)com

About Hissey Kientz, LLP
Hissey Kientz, LLP (http://www.hkllp.com) represents individuals affected by the side effects of GranuFlo and NaturaLyte, as well as victims of mesothelioma and other asbestos-related diseases, birth defects linked to the antidepressant drugs Zoloft, Lexapro, Celexa, Paxil and Effexor, problems with transvaginal mesh, DePuy ASR and Pinnacle hip replacements, Actos bladder cancer, birth defects caused by Topamax and other defective drugs and medical devices.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10322291.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. GranuFlo Lawsuit Consolidation Supported by Fresenius Medical Care, Bernstein Liebhard LLP Reports
2. Digital breast tomosynthesis cuts recall rates by 40 percent
3. Graphic warning labels improve smokers recall of warning and health risks related to smoking
4. US Drug Watchdog Now Urges All Recalled DePuy ASR Hip Implant Recipients Call Them For The Names Of The Best Attorneys Out Of Fear The Recipients Will Get Nothing
5. US Drug Watchdog Now Offers To Get A Free Legal Review For All DePuy ASR Recipients Who Received A Letter From Broadspire About Their Recalled DePuy Hip Implant
6. US Drug Watchdog Now Offers To Help All Recipients Of A DePuy Pinnacle Or Recalled DePuy ASR Hip Implant Get To The Best Attorneys Regardless If Their Device Has Failed
7. US Drug Watchdog Now Offers To Help Every Recipient Of A DePuy Pinnacle Or Recalled DePuy ASR Hip Implant Who Had To Go Through Revision Surgery Get To The Best Lawyers
8. US Drug Watchdog Dramatically Increases Their Efforts To Get All Recalled DePuy ASR Hip Implant Recipients Identified To The Best Possible Attorneys Before Time Runs Out
9. US Drug Watchdog Now Offers To Help All Recalled DePuy ASR Hip Implant Recipients Get To The Best Attorneys Out Of Fear These Recipients Won't Be Compensated
10. The US Drug Watchdog Now Offers To Help All Recipients Of Recalled DePuy ASR Hip Implant Get To The Best Attorneys Because Time Could Run Out To Get Them Identified
11. Imported Ricotta Cheese Recalled Due to Listeria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , ... December 05, 2016 , ... ... Plastic Surgery, is excited to announce the arrival of the newest Sciton laser ... with the ability to use tunable non-ablative and ablative wavelengths for exceptional results. ...
(Date:12/5/2016)... ... December 05, 2016 , ... SyncDog, Inc., the leading ... magazine, a leading online tech news platform connecting technology innovators with news, experience, ... explores the state of enterprise mobility security today, and how the SyncDog SentinelSecure™ ...
(Date:12/5/2016)... ... 05, 2016 , ... Worldwise ®, a leading consumer ... kathy ireland® Worldwide for five additional years, announced by Kevin Fick, Worldwise CEO. ... agreement three years ago to design and develop the kathy ireland® Loved Ones™ ...
(Date:12/5/2016)... ... December 05, 2016 , ... Physicians Education Resource®, ... International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on February ... are honored to have Amy E. Herman present at this year’s conference, her ...
(Date:12/5/2016)... , ... December 05, 2016 , ... BSI and Brenntag ... United States and Canada for distribution of their natural fruits and beverage ... is an exciting addition to our Life Sciences product portfolio,” said Steve Brauer, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Dec. 5, 2016   Mallinckrodt Pharmaceuticals (NYSE: ... company, today announced that it received a perfect score ... (CEI), a national benchmarking survey and report on corporate ... transgender (LGBT) workplace equality, administered by the Human Rights ... major U.S. businesses which also earned top marks this ...
(Date:12/5/2016)... , Dec. 5, 2016 Special purpose needles are ... such as fluid and cells from organs or lumps and ... and sizes. The global market for special purpose needles is ... In terms of revenue, the global special purpose needles market ... the forecast period (2016–2026) and is expected to be valued ...
(Date:12/5/2016)...   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... 2 clinical study of sotagliflozin, a dual SGLT1 and ... the leading global organization funding type 1 diabetes research. ... trial, which randomized a total of 87 patients, was ... dose of sotagliflozin compared to a placebo control in ...
Breaking Medicine Technology: